Journal article
Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
European cardiology, Vol.15, pp.e51-e51
01/01/2020
DOI: 10.15420/ecr.2020.16
PMCID: PMC7325211
PMID: 32617120
Abstract
The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respiratory symptoms, several reports have noted myocarditis, cardiomyopathy, arrhythmias and cardiac arrests as COVID-19 complications. Here, the authors highlight the current understanding of the pathophysiology of myocarditis related to COVID-19 and its management.
Details
- Title: Subtitle
- Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
- Creators
- Mahmoud Abdelnabi - Alexandria UniversityNouran Eshak - Texas Tech University Health Sciences CenterYehia Saleh - Michigan State UniversityAbdallah Almaghraby - Alexandria University
- Resource Type
- Journal article
- Publication Details
- European cardiology, Vol.15, pp.e51-e51
- DOI
- 10.15420/ecr.2020.16
- PMID
- 32617120
- PMCID
- PMC7325211
- NLM abbreviation
- Eur Cardiol
- ISSN
- 1758-3756
- eISSN
- 1758-3764
- Publisher
- Radcliffe Cardiology
- Language
- English
- Date published
- 01/01/2020
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984756261002771
Metrics
5 Record Views